CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

new morningstar report

  1. 4,660 Posts.
    lightbulb Created with Sketch. 57
    I got an update on CXS vis Westpac Broking from Morningstar saying high risk buy. Sorry can't post due to copyright but for those who can access it's worth a read.

    A snip though referring to the Hospira deal

    "The deal is better than we expected and more than validates our valuation which we increase from $1.40 to $1.60. This assumes peak patient numbers in the T3151 mutation niche of 2,000 by 2013, a drug price of A$65,000, a discount rate of 12%, and 10-year drug life."
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.